Adjuvant CMF (cyclophosphamide, methotrexate, fluorouracil) in breast cancer. Is it cost-effective?

被引：0
|
作者：
Norum, J [1 ]
机构：
[1] Univ Tromso Hosp, Dept Oncol, N-9012 Tromso, Norway
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)81319-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
899
引用
收藏
页码：S229 / S229
页数：1
相关论文
共 50 条
  • [1] Adjuvant cyclophosphamide, methotrexate, fluorouracil (CMF) in breast cancer - Is it cost-effective ?
    Norum, J
    ACTA ONCOLOGICA, 2000, 39 (01) : 33 - 39
  • [2] Adjuvant fluorouracil, epirubicin and cyclophosphamide in early breast cancer: Is it cost-effective?
    Norum, J
    Holtmon, M
    ACTA ONCOLOGICA, 2005, 44 (07) : 735 - 741
  • [3] CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE METHOTREXATE AND FLUOROURACIL (CMF) FOR BREAST-CANCER
    HOWELL, A
    BUSH, H
    GEORGE, WD
    HOWAT, JMT
    CROWTHER, D
    SELLWOOD, RA
    RUBENS, RD
    HAYWARD, JL
    BULBROOK, RD
    FENTIMAN, IS
    CHAUDARY, M
    BRITISH JOURNAL OF CANCER, 1984, 50 (02) : 253 - 253
  • [4] Hepatic toxicity during adjuvant cyclophosphamide, methotrexate and 5-Fluorouracil (CMF) in breast cancer
    Noberasco, C
    Peruzzotti, G
    Colleoni, M
    Nole, F
    deBraud, F
    Martinelli, G
    Goldhirsch, A
    ANNALS OF ONCOLOGY, 1998, 9 : 7 - 7
  • [5] ADJUVANT CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, METHOTREXATE AND FLUOROURACIL (CMF) IN EARLY BREAST-CANCER - MECHANISMS OF ACTION
    PADMANABHAN, N
    HOWELL, A
    RUBENS, RD
    BRITISH JOURNAL OF CANCER, 1986, 53 (03) : 431 - 432
  • [6] Population pharmacokinetics of adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF)
    Batey, MA
    Wright, JG
    Azzabi, A
    Newell, DR
    Lind, MJ
    Calvert, AH
    Boddy, AV
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (08) : 1081 - 1089
  • [7] MTHFR gene polymorphism and severe toxicity during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil (CMF)
    Toffoli, G
    Veronesi, A
    Boiocchi, M
    Crivellari, D
    ANNALS OF ONCOLOGY, 2000, 11 (03) : 373 - 374
  • [8] Comparison of CVF (Cyclophosphamide plus Vinorelbine+5-Fluorouracil) and CMF (Cyclophosphamide plus Methotrexate+5-Fluorouracil) Adjuvant Chemotherapy in Early Breast Cancer
    Gwak, Geumhee
    Park, Kyeongmee
    Shin, Eunah
    Han, Sehwan
    Kim, Ji-Young
    Kim, Hongyong
    Kim, Young Duk
    Kim, Hong Ju
    Kim, Ki Whan
    Bae, Byung Noe
    Yang, Keun Ho
    Cho, Hyunjin
    Park, Sung-Jin
    JOURNAL OF BREAST CANCER, 2011, 14 (03) : 223 - 228
  • [9] Side effects of cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) chemotherapy for breast cancer
    Sitzia, J
    Huggins, L
    CANCER PRACTICE, 1998, 6 (01) : 13 - 21
  • [10] Cyclophosphamide, methotrexate and infusional 5-fluorouracil (infusional CMF) in metastatic breast cancer
    O'Byrne, KJ
    Koukourakis, MI
    Saunders, MP
    Salisbury, AJ
    Isaacs, R
    Varcoe, S
    Taylor, M
    Ganesan, TS
    Harris, AL
    Talbot, DC
    BRITISH JOURNAL OF CANCER, 1998, 77 (11) : 1950 - 1956
12345